Home

Synopsys, Inc. - Common Stock (SNPS)

425.20
-12.90 (-2.94%)
NASDAQ · Last Trade: Sep 13th, 8:15 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Securities Fraud Investigation Into Synopsys, Inc. (SNPS) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) investors concerning the Company’s possible violations of the federal securities laws.
By Glancy Prongay & Murray LLP · Via Business Wire · September 12, 2025
Synopsys, Inc. (SNPS) Shares Suffer Worst Day Ever Amid Q325 Results Revealing Problems With Major Foundry Customer -- Hagens Berman
On September 10, 2025, investors in Synopsys, Inc. (NASDAQ: SNPS) saw the price of their shares crater over $216 (-36%) after the company reported its Q3 2025 financial results and revealed significant problems with a major foundry customer.
By Hagens Berman · Via Business Wire · September 11, 2025
Synopsys, Inc. (SNPS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Howard G. Smith · Via Business Wire · September 11, 2025
Synopsys Inc. (NASDAQ: SNPS) Making Surprising Moves in Thursday Session
Synopsys, Inc. (NASDAQ: SNPS) has caught the attention of the investment community today with its bullish price action. The company’s shares have moved 10.71% on the day to $601.83.
Via Investor Brand Network · February 22, 2024
Synopsys Inc. (NASDAQ:SNPS) Records 52-Week High Thursday Morning
Shares of Synopsys, Inc. (NASDAQ: SNPS) traded at a new 52-week high today and are currently trading at $499.7. So far today, approximately 149.72k shares have been exchanged, as compared to an average 30-day volume of 770.37k shares.
Via Investor Brand Network · October 12, 2023
Securities Fraud Investigation Into Synopsys, Inc. (SNPS) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) on behalf of investors concerning the Company’s possible violations of federal securities laws.
By Law Offices of Frank R. Cruz · Via Business Wire · September 11, 2025
SNPS Investors Have Opportunity to Join Synopsys, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · September 10, 2025
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX
Synopsys, Inc. Named Outstanding Leader, Nell Triplett of Juniper Networks Awarded Outstanding Executive, and IDEXX Laboratories, Inc. Recognized as Breakthrough Corporate Leader
By Sustainability Roundtable Inc. · Via GlobeNewswire · December 19, 2024
Synopsys: Looking to Stay Ahead of Industry Trends after Solid Q3
Synopsys beat estimates on adjusted earnings per share and revenue. Answers to questions in the earnings call also gave positive signals.
Via MarketBeat · August 23, 2024
Semiconductor Stock Giant Beats on EPS, Faces Large Backlog
Cadence Systems beat earnings per share expectations but provided a guidance downgrade. It should ramp up manufacturing to meet hardware demand.
Via MarketBeat · July 24, 2024
Arm Holdings Stock Soars: Powering the Edge AI Revolution with v9
U.K. based semiconductor company Arm Holdings plc (NASDAQ: ARM) stock is up 141% year-to-date (YTD). The artificial intelligence (AI) revolution
Via MarketBeat · July 8, 2024
NVIDIA Stock: Priced for Perfection or Poised for a Correction?
Nvidia's stock performance reflects a delicate balance between strong growth in AI and the potential risks associated with its lofty valuation.
Via MarketBeat · July 3, 2024
Silvaco Stock: Consider Early Investment in New Semiconductor
Analyzing a new player in semiconductors: Silvaco Group. Investors should consider getting in early on the stock after a solid earnings report.
Via MarketBeat · June 26, 2024
Autodesk Stock Up 25%, Analysts Want More Double-Digit Gains
Autodesk shares already had a 25% run on recent earnings, but the rest of the market - and Wall Street analysts - expect to see another double-digit run
Via MarketBeat · June 20, 2024
Keysight, Synopsys, and Ansys Deliver Radio Frequency Design Migration Flow to TSMC’s N6RF+ Process Node
Keysight Technologies, Inc. (NYSE: KEYS), Synopsys, Inc. (Nasdaq: SNPS), and Ansys (Nasdaq: ANSS) introduce a new integrated radio frequency (RF) design migration flow from TSMC’s N16 process to its N6RF+ technology to address the power, performance, and area (PPA) requirements of today’s most demanding wireless integrated circuit applications. The new migration workflow integrates millimeter wave (mmWave) and RF solutions from Keysight, Synopsys, and Ansys into an efficient design flow that streamlines re-design of passive devices and design components to TSMC’s more advanced RF process.
By Keysight Technologies, Inc. · Via Business Wire · April 24, 2024
Wall Street is surprisingly most bullish on these 3 Nasdaq stocks
Analysts are gradually shifting toward underperforming, less prominent names to find the next big thing - including these three current Wall Street faves
Via MarketBeat · February 14, 2024
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
BALA CYNWYD, Pa., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · January 26, 2024
These 5 growth stocks are now in buy ranges
Affirm, MongoDB, UIPath, Synopsys and Crispr's charts signal buy opportunities as these top-performing tech and biotech stocks consolidate below prior highs.
Via MarketBeat · January 25, 2024
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
BALA CYNWYD, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · January 22, 2024
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
BALA CYNWYD, Pa., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · January 16, 2024
AstraZeneca: Rebound in 2024 with double-digit earnings growth
AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition
Via MarketBeat · January 11, 2024
Synopsys stock: Unsung hero of the AI revolution
Synopsis, the leading provider of electronic design automation software, is up more than 60% in 2023 as customers AMD, Nvidia and Intel expand AI capabilities.
Via MarketBeat · December 29, 2023
Synopsys offers to acquire Ansys, sparks stock surge
Ansys stock rose 18% on Synopsys acquisition news. Fellow engineering software maker Altair also rose on speculation it may be an acquisition target.
Via MarketBeat · December 27, 2023
Keysight, Synopsys, and Ansys Accelerate RFIC Semiconductor Design with New Reference Flow for TSMC’s Advanced 4nm RF FinFET Process
Keysight Technologies, Inc. (NYSE: KEYS), Synopsys, Inc. (Nasdaq: SNPS), and Ansys (Nasdaq: ANSS) announced a new reference flow for the TSMC N4PRF, the world’s leading semiconductor foundry’s advanced 4 nanometer (nm) radio frequency (RF) FinFET process technology. The reference flow is based on the Synopsys Custom Design Family, which provides a complete RF design solution for customers seeking an open RF design environment with higher predictive accuracy and productivity. It provides designers with a choice of best-in-class solutions and includes validated integrations with radio frequency integrated circuit (RFIC) design and interactive electromagnetic (EM) analysis tools from Keysight and EM modeling and signoff power integrity solutions from Ansys.
By Keysight Technologies, Inc. · Via Business Wire · September 27, 2023
3 Reasons Unity Software Is Ready to Rally 38%
Unity Software nabbed a "buy" upgrade from Bank of America, shedding light on the software developer's untapped potential. Analysts expect EPS to grow by 79%.
Via MarketBeat · September 26, 2023